The IQ-1S JNK (c-Jun N-Terminal Kinase) Inhibitor Suppresses Premature Aging of OXYS Rat Brain; Neurochemical Journal; Vol. 17, iss. 3
| Parent link: | Neurochemical Journal=Нейрохимия.— .— Cham: Springer International Publishing Vol. 17, iss. 3.— 2023.— P. 369–379 |
|---|---|
| Other Authors: | Zhdankina A. A. Anna Aleksandrovna, Osipenko A. N. Anton Nikolaevich, Tikhonov D. I., Logvinov S. V. Sergey Valentinovich, Plotnikov M. B. Mark Borisovich, Khlebnikov A. I. Andrey Ivanovich, Kolosova M. G. Nataliya Gorislavovna |
| Summary: | Title screen According to the Alzheimer’s Disease International (ADI) international organization about 50 million people in the world suffer from Alzheimer’s disease (AD). However, there are no effective methods for preventing or slowing the progression of AD. Inhibition of the c-Jun N-terminal kinase (JNK) signaling pathway is discussed below as an alternative way to prevent the development of AD and other neurodegenerative diseases. In the present study, we evaluated the ability of a recently synthesized selective JNK3 inhibitor, 11H-indeno[1,2-b]quinoxalin-11-one oxime sodium salt (IQ-1S), to suppress neurodegenerative processes in OXYS rats at an early stage of development of AD at the ages of 4.5 to 6 months. Treatment with IQ-1S (50 mg/kg intragastrically) led to the suppression of the development of neurodegenerative processes in the cerebral cortex of OXYS rats: an increase in the proportion of unchanged neurons, a decrease in the proportion of neurons with signs of destruction and irreversible damage, and a normalization of the glioneuronal index, which was facilitated by a decrease in the severity of hyperviscosity syndrome blood in OXYS rats. The use of the IQ-1S JNK3 inhibitor may be a promising strategy for the prevention of early neurodegenerative disorders and, possibly, the treatment of AD Текстовый файл AM_Agreement |
| Language: | English |
| Published: |
2023
|
| Subjects: | |
| Online Access: | https://doi.org/10.1134/S1819712423030212 Статья на русском языке |
| Format: | Electronic Book Chapter |
| KOHA link: | https://koha.lib.tpu.ru/cgi-bin/koha/opac-detail.pl?biblionumber=680410 |
Similar Items
Pharmacokinetics of a New Neuroprotector — Indenoquinoxalinone Derivative after Intravenous Administration in Rabbits and Rats; Bulletin of Experimental Biology and Medicine; Vol. 175, iss. 6
Published: (2023)
Published: (2023)
Effect of IQ-1 on the Infarct Size and the Parameters of Cardiodynamic Indicators in the Acute Period after Myocardial Ischemia/Reperfusion in Rats; Bulletin of Experimental Biology and Medicine; Vol. 176, iss. 4
Published: (2024)
Published: (2024)
Antihypertensive activity of a new c-Jun N-terminal kinase inhibitor in spontaneously hypertensive rats; Hypertension Research; Vol. 43
Published: (2020)
Published: (2020)
Alterations of JNK Signaling Pathway Activity in the Rat Retina: Effects of Age, Age-Related Macular Degeneration-like Pathology, and a JNK Inhibitor (IQ-1S); Cells; Vol. 14, iss. 12
Published: (2025)
Published: (2025)
JNK Signaling Pathway Activity Alterations in the Rat Hippocampus: Effect of Age, Alzheimer’s Disease-Like Pathology Development, and the JNK Inhibitor IQ-1S; Biochemistry (Moscow); Vol. 90, iss. 2
Published: (2025)
Published: (2025)
Novel c-Jun N-Terminal Kinase (JNK) Inhibitors with an 11H-Indeno[1,2-b]quinoxalin-11-one Scaffold; Molecules; Vol. 26, iss. 18
Published: (2021)
Published: (2021)
Evaluation of Nitric Oxide-Donating Properties of 11H-indeno[1,2-b]quinoxalin-11-one Oxime (IQ-1) by Electron Paramagnetic Resonance Spectroscopy; Molecules; Vol. 29, iss. 16
Published: (2024)
Published: (2024)
Synthesis, biological evaluation, and molecular modeling of 11H-indeno[1,2-b]quinoxalin-11-one derivatives and tryptanthrin-6-oxime as c-Jun N-terminal kinase inhibitors; European Journal of Medicinal Chemistry; Vol. 161
Published: (2018)
Published: (2018)
Cardioprotective Effects of a Selective c-Jun N-terminal Kinase Inhibitor in a Rat Model of Myocardial Infarction; Biomedicines; Vol. 11, iss. 3
Published: (2023)
Published: (2023)
Design, synthesis and biological evaluation of novel O-substituted tryptanthrin oxime derivatives as c-Jun N-terminal kinase inhibitors; Frontiers in Pharmacology; Vol. 13
Published: (2022)
Published: (2022)
Neuroprotective Effects of the Lithium Salt of a Novel JNK Inhibitor in an Animal Model of Cerebral Ischemia-Reperfusion; Biomedicines; Vol. 10, iss. 9
Published: (2022)
Published: (2022)
Comparative Evaluation of Neuroprotective Activity of Tryptanthrin and Its Oxime in Middle Cerebral Artery Occlusion in Rats; Bulletin of Experimental Biology and Medicine; Vol. 177, iss. 3
Published: (2024)
Published: (2024)
The Effect of Tryptanthrin and Its Oxime on the Blood–Brain Barrier Permeability in Rats with Cerebral Infarction; Bulletin of Experimental Biology and Medicine; Vol. 179, iss. 2
Published: (2025)
Published: (2025)
Suppression of Age-Related Macular Degeneration-like Pathology by c-Jun N-Terminal Kinase Inhibitor IQ-1S; Biomedicines; Vol. 11, iss. 2
Published: (2023)
Published: (2023)
11H-Indeno[1,2-b]quinoxalin-11-one 2-(4-Ethylbenzylidene)hydrazone; Molbank; Vol. 2021, iss. 4
by: Kovrizhina A. R. Anastasia Ruslanovna
Published: (2021)
by: Kovrizhina A. R. Anastasia Ruslanovna
Published: (2021)
Regulation of Blood–Brain Barrier Permeability via JNK Signaling Pathway: Mechanisms and Potential Therapeutic Strategies for Ischemic Stroke, Alzheimer’s Disease and Brain Tumors; Molecules; Vol. 30, iss. 11
Published: (2025)
Published: (2025)
c-Jun N-Terminal Kinases and Their Pharmacological Modulation in Ischemic and Reperfusion Brain Injury; Neuroscience and Behavioral Physiology; Vol. 48, iss. 6
Published: (2019)
Published: (2019)
c-Jun N-Terminal Kinases (JNKs) in Myocardial and Cerebral Ischemia/Reperfusion Injury; Frontiers in Pharmacology; Vol. 9
Published: (2018)
Published: (2018)
c-Jun N-Terminal Kinase (JNK) Inhibitor IQ-1S as a Suppressor of Tumor Spheroid Growth; Molecules; Vol. 30, iss. 21
Published: (2025)
Published: (2025)
Inhibitory effect of IQ-1S, a selective c-Jun N-terminal kinase (JNK) inhibitor, on phenotypical and cytokine-producing characteristics in human macrophages and T-cells; European Journal of Pharmacology; Vol. 878
Published: (2020)
Published: (2020)
Novel Tryptanthrin Derivatives with Selectivity as c–Jun N–Terminal Kinase (JNK) 3 Inhibitors; Molecules; Vol. 28, iss. 12
Published: (2023)
Published: (2023)
Protective Effects of a New C-Jun N-terminal Kinase Inhibitor in the Model of Global Cerebral Ischemia in Rats; Molecules; Vol. 24, iss. 9
Published: (2019)
Published: (2019)
Poly(ε-caprolactone) Scaffolds Doped with c-Jun N-terminal Kinase Inhibitors Modulate Phagocyte Activation; ACS Biomaterials Science and Engineering; Vol. 5, iss. 11
Published: (2019)
Published: (2019)
Experimental and Computational Investigation of the Oxime Bond Stereochemistry in c-Jun N-terminal Kinase 3 Inhibitors 11H-Indeno[1,2-b]quinoxalin-11-one Oxime and Tryptanthrin-6-oxime; Pharmaceutics; Vol. 15, iss. 7
Published: (2023)
Published: (2023)
Оксим инденохиноксалинона IQ-1 как перспективный агент для разработки лекарственных препаратов; Перспективы развития фундаментальных наук; Т. 2 : Химия
by: Коврижина А. Р. Анастасия Руслановна
Published: (2024)
by: Коврижина А. Р. Анастасия Руслановна
Published: (2024)
Alarmins and c-Jun N-Terminal Kinase (JNK) Signaling in Neuroinflammation; Cells; Vol. 9, iss. 11
Published: (2020)
Published: (2020)
Therapeutic Effect of Novel Cyanopyrrolidine-Based Prolyl Oligopeptidase Inhibitors in Rat Models of Amnesia; Frontiers in Chemistry; Vol. 9
Published: (2021)
Published: (2021)
Development and validation of HPLC-UV method for quantitation of a new antithrombotic drug in rat plasma and its application to pharmacokinetic studies; Journal of Chromatography B; Vol. 1160
Published: (2020)
Published: (2020)
Geochemistry and mineralogy of rare earth elements in high-phosphorus ooidal ironstones: A case study of the Kamysh-Burun deposit (Azov–Black Sea iron Province); Ore Geology Reviews; Vol. 127
Published: (2020)
Published: (2020)
Влияние плотности посадки кижуча (Oncorhynchus kisutch (Walbaum)) на содержание гормонов стресса и выживаемость потомства; Экология; № 2
by: Ардашев А. А.
Published: (2002)
by: Ардашев А. А.
Published: (2002)
Tricyclic Isatin Derivatives as Anti-Inflammatory Compounds with High Kinase Binding Affinity; Molecules; Vol. 30, iss. 14
Published: (2025)
Published: (2025)
A review of Brain-Computer Interface technology; Control and Communications (SIBCON)
by: Stankevich Ph. V. Philippe Vladimirovich
Published: (2015)
by: Stankevich Ph. V. Philippe Vladimirovich
Published: (2015)
Алгебра и начала анализа: учебник
by: Башмаков М. И. Марк Иванович
Published: (Москва, Просвещение, 1993)
by: Башмаков М. И. Марк Иванович
Published: (Москва, Просвещение, 1993)
Новгородская служебная Минея на май. XI век. (Путятина Минея): Текст. Исследования. Указатели
Published: (Ижевск, Удмурдский университет, 2003)
Published: (Ижевск, Удмурдский университет, 2003)
Synthesis and biological evaluation of alkali metal salts of tryptanthrin-6-oxime; 53rd International Union of Pure & Applied Chemistry General Assembly (IUPAC 2025) and 50th World Chemistry Congress (50WCC)
by: Kovrizhina A. R. Anastasia Ruslanovna
Published: (2025)
by: Kovrizhina A. R. Anastasia Ruslanovna
Published: (2025)
Из "Шах-наме"
by: Фирдоуси А. Абулькасим
Published: (Москва, Художественная литература, 1969)
by: Фирдоуси А. Абулькасим
Published: (Москва, Художественная литература, 1969)
Neuroprotective Effects of Tryptanthrin-6-Oxime in a Rat Model of Transient Focal Cerebral Ischemia; Pharmaceuticals; Vol. 16, iss. 8
Published: (2023)
Published: (2023)
История России. Киевская Русь
by: Вернадский Г. В. Георгий Владимирович
Published: (Москва, Леан, 1996)
by: Вернадский Г. В. Георгий Владимирович
Published: (Москва, Леан, 1996)
Кн. 2: Иконы ХI-XIII веков; Русская иконопись
Published: (1983)
Published: (1983)
Философско-мировоззренческое содержание "Изборников" 1073 и 1076 годов
by: Бондарь С. В. Станислав Васильевич
Published: (Киев, Наукова думка, 1990)
by: Бондарь С. В. Станислав Васильевич
Published: (Киев, Наукова думка, 1990)
Similar Items
-
Pharmacokinetics of a New Neuroprotector — Indenoquinoxalinone Derivative after Intravenous Administration in Rabbits and Rats; Bulletin of Experimental Biology and Medicine; Vol. 175, iss. 6
Published: (2023) -
Effect of IQ-1 on the Infarct Size and the Parameters of Cardiodynamic Indicators in the Acute Period after Myocardial Ischemia/Reperfusion in Rats; Bulletin of Experimental Biology and Medicine; Vol. 176, iss. 4
Published: (2024) -
Antihypertensive activity of a new c-Jun N-terminal kinase inhibitor in spontaneously hypertensive rats; Hypertension Research; Vol. 43
Published: (2020) -
Alterations of JNK Signaling Pathway Activity in the Rat Retina: Effects of Age, Age-Related Macular Degeneration-like Pathology, and a JNK Inhibitor (IQ-1S); Cells; Vol. 14, iss. 12
Published: (2025) -
JNK Signaling Pathway Activity Alterations in the Rat Hippocampus: Effect of Age, Alzheimer’s Disease-Like Pathology Development, and the JNK Inhibitor IQ-1S; Biochemistry (Moscow); Vol. 90, iss. 2
Published: (2025)